A&D Pharma, which has a turnover of around EUR800 million, owns the largest drug wholesaler (Mediplus), the widest pharmacy network (Sensiblu) and it has recently launched the Anima private clinics.
Diagnosis clinics were held half by investment fund Gemisa, and half by Cristina Manea, Dan Ionescu and Adrian Pop. Following the transaction, whose value was not disclosed, Cristina Manea and Gemisa exited the company.
“A&D Pharma shareholders were already present in Diagnosis and we thought the occupational medicine portfolio, with 40,000 subscribers, was interesting,” said Cristian Sas, chief operating officer of Anima.
The A&D Pharma group is controlled by businessmen Walid Abboud, Roger Akoury, Ludovic Robert and Michel Eid. The first three also control Gemisa Investments.
Sas says this year Anima expects a turnover of EUR5 million, since Anima’s turnover in 2011 was EUR2 million, with Diagnosis posting similar figures.
The transaction marks a powerful start of the year for the private medical services market, after 2011 saw record-high investments in opening private hospitals.
(English version by Daniela Stoican)